Review Article | Open Access
Evaluation of Chemical Constituents and Important Mechanism of Pharmacological Biology in Dendrobium Plants
Dendrobium species, commonly known as “Shihu” or “Huangcao,” represents the second largest genus of Orchidaceae, which are used commonly as tonic herbs and healthy food in many Asian countries. The aim of this paper is to review the history, chemistry, and pharmacology of different Dendrobium species on the basis of the latest academic literatures found in Google Scholar, PubMed, Sciencedirect, Scopus, and SID.
The origin of orchids (Orchidaceae) probably has to be backdated to 120 million years ago. It is the largest family group among angiosperms, as well as the most highly evolved family of the flowering plants, with approximately 25,000 to 35,000 species under 750 to 900 genera [1–4]. Dendrobium species, commonly known as “Shihu” or “Huangcao,” is the second largest genus in Orchidaceae. Most Dendrobium species grow best in relatively high and mountainous areas, at 1400–1600 m above sea level, at a mild temperature, and in a humid and foggy environment. Characterized by a broad geographical distribution, which allows Dendrobium species to grow into tremendous diversities producing a large number of interspecific hybrids with different morphological features, they are widely distributed in Asia, Australia, and Europe, for instance, in India, Sri Lanka, China, Japan, Korea, New Guinea, and New Caledonia . In the early age, using molecular approaches would delimit the subtribe-Dendrobiinae, affecting approximately 1100 species (900 in Dendrobium Sw.) from Indo-Asian and Pacific regions [6, 7], and more than 1200 species in Australasia are from various Dendrobium species. Today, Indo-Asian and Pacific regions have one of the largest and most diverse and taxonomically problematic orchid groups . Interestingly, there has been a long history of the usage of first-rate herbs and folk traditional herbs in India and China .
Since the ancient times (600 B.C.) in India, the oldest references regarding the use of medicinal herbs are found in the Sanskrit literature, namely, “Charaka Samhita.” The earliest treatise on “Ayurveda” describes the property of plant drugs and their uses. In the Ayurvedic system of medicine, Flickingeria macraei is used in “Ayurveda.” It is commonly named as “jeevanti” and is used as an astringent to the bowels, as an aphrodisiac, and in asthma and bronchitis . Other commonly used orchid drugs in the Ayurvedic system are salem, including jewanti (Dendrobium alpestre). Similarly, it is the first time for China to regard orchids as herbal medicines . The Emperor “Shen-Nung” advised on the medicinal properties of Dendrobium species in “materia medica” in the 28th century B.C. . As early as 200 B.C., the Chinese pharmacopoeia “The Sang Nung Pen Tsao Ching” mentioned Dendrobium as a source of tonic, astringent, analgesic, and anti-inflammatory substances . In Song Dynasty (960–1279 A.D.). It mentioned the medicinal uses of orchids, namely Dendrobium species according A Diagnosis of Medical Herbs from the “Zheng Lei Ben Cao”. In Ming Dynasty (1368–1644) many references on the use of orchids as medicinal herbs were available .
2. The Chemical Compounds of Dendrobium Species
The stem of Dendrobium species has been used in traditional Chinese medicine as a tonic and antipyretic since ancient days for treating human disorders. However, misidentification and adulteration led to a loss of therapeutic potency and potential intoxication. For decades, fast developing molecular techniques using DNA fingerprinting, DNA sequencing, and DNA microarray have been applied extensively to authenticate Chinese medicinal materials, including various Dendrobium species , namely, D. aphyllum, D. candidum, D. chrysanthum, D. densiflorum, D. huoshanense, D. gratiosissimum, D. longicornu, D. nobile, D. secundum, D. chrysotoxum, D. crystallinum, D. fimbriatum, and others . In the early years, Williams and Harborne conducted a major survey of leaf flavonoids at the Plant Science Laboratories of the University of Reading in UK. They conducted research on 142 species belonging to 75 genera and found that the most common constituents were flavone C-glycoside and flavonols . Since then, about 100 compounds from 42 Dendrobium species including 32 alkaloids, 6 coumarins, 15 bibenzyls, 4 fluorenones, 22 phenanthrenes, and 7 sesquiterpenoids constituents have been discussed and reviewed [18–31] (Table 1). To date, various Dendrobium species are known to produce a variety of secondary metabolites. The biological activities and pharmacological actions of all of these compounds were investigated in detail [32–39].
3. The Pharmacological Effects of Dendrobium Species
3.1. Antioxidant Activities
Oxidative stress is induced by free radicals that participate in a variety of chemical reactions with biomolecules, leading to a pathological condition. Reactive oxygen species (ROS) is one of the major free radicals. It mainly comprises superoxide () and nitric oxide (NO) radicals, including (1) catalase (CAT), (2) peroxidase (POD), (3) ascorbate peroxidase (APX), (4) 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) or ABTS, (5) hydroxyl, and (6) 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals. During these processes, it was found that the content of malondialdehyde (MDA) was increased.
However, cells possess two distinctive antioxidant defense systems to counteract the damage, including enzymatic antioxidants and nonenzymatic antioxidants. Enzymatic antioxidants comprise catalase, superoxide dismutase (SOD), glutathione peroxidase (GPx), and others associated with enzymes/molecules. Nonenzymatic antioxidants include ascorbic acid (vitamin C), α-tocopherol (vitamin E), and β-carotene, which play a key role in removing reactive oxygen species.
Oxidative stresses have been classified as exogenous factors and endogenous factors. Factors related to environmental stress include water/soil drought stress, chilling injury stress, and sound wave stress. There were studies on the effects of cold storage on cut Dendrobium inflorescences, showing that chilling injury symptoms for floral buds and open flowers of Dendrobium could lead to oxidative stress, stemming from the production of reactive oxygen species. In this process, the decrease of cellular functions by peroxidation of membrane lipids when lipoxygenase enzymes are degraded in cells. However, this physiological process in floral buds and open flowers is part of antioxidant defense systems, which can decrease the content of oxygen free radicals and other oxygen compounds. It indicates the protective cellular functions and antioxidant capacity. This is an adaptive nature to ensure some plants survive in the freezing winter .
In addition, sound wave stress is one of the environmental stresses, similar to the low temperature stress. Studies of the effects of sound wave stress on D. candidum yielded data indicated it as a lipid peroxidation parameter which can regulate the levels of MDA. Firstly, the MDA content in different organs is increased and then declines afterwards, which will then be followed by an increase again. That gives a net increase of the level of MDA. It was noted that the MDA level appears to be the lowest when the activities of antioxidant enzymes are the highest. However, the levels of MDA are yet to be fully understood. We believe the antioxidant enzymes could protect plant cells from oxidative damage in sound wave stress . However, the correlation between the mechanisms of antioxidant action and the sound wave stress and chilling injury stress has yet to be identified.
Water deficit caused by soil drought is one of the most frequent environmental stresses. The effects of exogenous drought menace, prompting further increases in the activity of ROS and decrease in the malondialdehyde (MDA) content, to prevent the breakage of DNA and protein degradation from doing damage to plant life . It is well known that nitric oxide (NO) is a ubiquitous signal molecule involved in many life processes of plants, seed germination, hypocotyl elongation, leaf, expansion, root growth, lateral roots initiation, and apoptosis, and so forth. It is also involved in multiple plant responses to environmental stress. Data demonstrated that, at lower concentrations of exogenous NO with 50 mmol L−1 SNP, the activation of POD, SOD, and CAT was significantly increased, and the MDA content decreased with 50Ml SNP.NO could protect D. huoshanense against the oxidative insult caused by a drought stress; meanwhile, a high level of RWC can be maintained. Furthermore, it suggests that the molecular messenger NO can trigger epigenetic variation and increase the demethylation ratio of methylated sites for D. huoshanense by using DNA analysis. These results may imply that the expression of some genes is involved in the response to drought stress triggered by NO .
Numerous Dendrobium species such as D. nobile, D. denneanum, D. huoshanense, D. chrysotoxum, D. moniliforme, D. tosaense, D. linawianum, D. candidum, D. loddigesii, and D. fimbriatum have polysaccharides as the active compounds. Polysaccharides play important roles in many biological processes and are used to treat various diseases [66, 67]. Polysaccharides isolated from D. nobile, D. huoshanense, D. chrysotoxum, and D. fimbriatum species manifest antioxidant and free radical scavenging activities. D. nobile polysaccharide displayed the highest scavenging activity toward hydroxyl, ABTS, and DPPH free radicals [40, 68, 69]. However, D. fimbriatum polysaccharide has significant scavenging action toward ABTS free radicals, and it also shows a weak DPPH free radical scavenging action. On the contrary, D. denneanum polysaccharide exerts a powerful DPPH free radical scavenging action, but its ABTS scavenging effect is not obvious . In addition, both D. huoshanense and D. chrysotoxum polysaccharides reveal an insufficient ABTS free radical scavenging effect. However, it manifests potential hydroxyl radical scavenging activity. Overall, the free radical scavenging activities of polysaccharides on hydroxyl and DPPH free radicals remain at a high level, but the inhibitory effect on ABTS free radicals is weak. The above results, compared with other types of polysaccharides from D. denneanum and D. nobile, are shown in Tables 2 and 3, and others are shown in Table 4 [41, 53]. The polysaccharide of D. huoshanense has a backbone of ()-linked α-D-Glcp, ()-linked α-D-Glcp, and ()-linked β-D-Manp from mannose (Man), glucose (Glc), and a trace of galactose (Gal). Its antioxidant effect in the livers of CCl4-treated mice was evidenced by a decrease of malondialdehyde (MDA) and increase of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) .
|Notes: Low (LW); High (HH).|
Up the table: the antioxidant effect of DNP4-2 on ABTS, hydroxyl, and DPPH free radicals, suggesting the levels of DNP4-2 higher than DNP1-1, DNP2-1, and DNP3-1; however, the antioxidant effects of DDP2-1 on hydroxyl and DPPH free radicals were higher than ABTS free radicals. Moreover, the DDP1-1 and DDP 3-1 on inhibitory effect were low than other compounds. We believe that the focus on antioxidant potential of DNP4-2 and DDP2-1 structures in near future.
|Up the table: it is shown that DPPH and ABTS free radical scavenging (%) of DNP4-2 are better than other compounds; however, the hydroxyl free radical scavenging (%) of DNP is better than other compounds.|
|Notes: —: no tests and about: AB.|
The scavenging hydroxyl free radicals abilities of polysaccharides from D. huoshanense and D. chrysotoxum are stronger than D. fimbriatum, and the scavenging ABTS free radicals abilities of polysaccharides from D. fimbriatum are stronger than D. huoshanense and D. chrysotoxum polysaccharides. Results showed that polysaccharides (scavenging DPPH effects %) from D. huoshanense and D. chrysotoxum are higher than hydroxyl and ABTS. And polysaccharides (scavenging ABTS effects %) from D. fimbriatum are higher than DPPH and hydroxyl free radicals.
3.1.1. The Antioxidant Activities of Bibenzyl Derivatives, Phenanthrenes, and Stilbenes from D. candidum and D. loddigesii
Four new bibenzyl derivatives, dendrocandin F, dendrocandin G, dendrocandin H, and dendrocandin I, are extracted from D. candidum. They act as antioxidant agents to clear up the free radicals. Accordingly, the IC50 values of dendrocandin F and dendrocandin G are 55.8 mM and 32.4 mM, respectively . A series of structurally related compounds from D. loddigesii, known as loddigesiinol A–D, suppress the production of nitric oxide (NO) with IC50 values of 2.6 mM for loddigesiinol A, 10.9 mM for loddigesiinol B, and 69.7 mM for loddigesiinol D. Further study indicated that phenanthrenes and dihydrophenanthrenesin D. loddigesii have significant effects on inhibiting the production of NO and DPPH free radicals. These compounds are known as (numbered as 1a–7a) phenanthrenes (1a), phenanthrenes (2a), phenanthrenes (3a), phenanthrenes (4a), dihydrophenanthrenes (5a), dihydrophenanthrenes (6a), and dihydrophenanthrenes (7a). Based on the above results, the scavenging activity of loddigesiinols toward NO free radicals is pronounced. The inhibitory actions of phenanthrenes and dihydrophenanthrenes from D. loddigesii on the production of NO and DPPH free radicals are recognised. The relevant data and information are shown in Table 5 .
|Notes: —: no tests; RO: relation composition.|
Inhibitory effects of different compounds from D. loddigesii and D. nobile species on NO production. Result shown in Table 5, ranked from high to low as follows: loddigesiinol D > R1 = R2 = R3 = OCH3 R4 = H (5) > nobilone F (3) > R1 = OCH3 R2 = R3 = OH R4 = H (8) > R1 = R3 = OH R2 = R4 = H (9) > dihydrophenanthrenes (7a) > dihydrophenanthrenes (6a) > nobilin E (2) > nobilin D (1) > R1 = R3 = OH R2 = H R4 = OCH3 (10) > phenanthrenes (4a) = loddigesiinols B > phenanthrenes (2a) > phenanthrenes (3a) > dihydrophenanthrenes (5a) > phenanthrenes (1a) > loddigesiinols A, and all of the compounds inhibit DPPH prodruction (from high to low): dihydrophenanthrenes (5a) > phenanthrenes (2a) > phenanthrenes (1a) > loddigesiinol C > phenanthrenes (3a).
3.2. Anti-Inflammatory Activity
3.2.1. Inhibition of Nitric Oxide (NO) by D. nobile and D. chrysanthum Constituents
It is known that, upon lipopolysaccharide (LPS) stimulation, macrophages produce a large amount of inflammatory factors, such as tumor necrosis factor α (TNF-α), interleukin-1 beta (IL-1β), interleukin 6 (IL-6), interferon (IFN), and other cytokines. LPS induces endogenous nitric oxide (NO) biosynthesis through induction of inducible nitric oxide synthase (iNOS) in macrophages, which is involved in inflammatory responses . D. nobile and D. chrysanthum constituents strongly inhibit TNF-α, IL-1β, IL-6, and the NO production.
3.2.2. D. nobile Constituents
From D. nobile two new bibenzyl derivatives, namely, nobilin D (given number 1) and nobilin E (given number 2), and a new fluorenone, namely, nobilone (given number 3), together with seven known compounds (given numbers 4–10), including R1 = R2 = OCH3 R3 = OH R4 = H (4), R1 = R2 = R3 = OCH3 R4 = H (5), R1 = R2 = OH R3 = R4 = H (6), R1 = R3 = OCH3 R2 = OH R4 = H (7), R1 = OCH3 R2 = R3 = OH R4 = H (8), R1 = R3 = OH R2 = R4 = H (9), and R1 = R3 = OH R2 = HR4 = OCH3 (10), have been identified. Compounds 1–3, 5, and 8–10 can inhibit NO production. On the other hand, compounds 2 and 10 can exhibit a strong to resveratrol, while enhanced cytotoxic potential has been found in compounds 4 and 7. Compounds 1–10 act as NO inhibitors, as evidenced by oxygen radical absorbency capacity (ORAC) assays. These findings are focused on all of these compounds, except compound 6, and their inhibitory effects on NO production, in murine macrophages (RAW 264.7), activated by LPS and interferon (IFN-ç) are shown in Table 5 . Furthermore, it was found that a new phenanthrene, together with nine known phenanthrenes and three known bibenzyls, manifests an inhibitory effect on NO production in RAW 264.7 cells. The structures of all of the compounds (given numbers A–M), including R1 = R3 = OH, R2 = R5 = OCH3, R4 = H(A), R1 = R4 = R5 = OH, R2 = H, R3 = OCH3(B), R1 = R5 = OH, R2 = R3 = OCH3, R4 = H(C), R1 = R2 = OCH3, R3 = R5 = OH, R4 = H(D), R1 = H R2 = R3 = OH(E), R1 = H, R2 = OH, R3 = OCH3(F), R1 = OCH3, R2 = R4 = OH, R3 = R5 = H(G), R1 = R3 = OH, R2 = OCH3(H), R1 = R5 = OH, R2 = R4 = H, R3 = OCH3(I), R1 = R3 = OCH3, R2 = R5 = OH, R4 = H(J), R1 = R2 = R4 = OH, R3 = OCH3, R5 = H(K), R1 = OCH3, R2 = R4 = H, R3 = R5 = OH(L), and R1 = R2 = R3 = OH, R4 = R5 = H(M), were elucidated by analysis of the spectroscopic data, including extensive two-dimensional nuclear magnetic resonance spectroscopy (2D-NMR) and mass spectrometry (MS). All of compounds C, D, I, K, and L are relatively strong inhibitors of NO production, and their potencies are better than those of compounds A and E–H . Compounds C, D, I, K, and L could inhibit NO synthesis which might contribute to the suppression of LPS-induced TNF-α and IL-1β production.
3.2.3. D. chrysanthum Constituents
Anti-inflammatory compounds from ethyl acetate extracts of D. chrysanthum species were evaluated. These structures were elucidated on the basis of the high-resolution mass spectrometry, NMR spectroscopy, and X-ray crystal diffraction analysis. A novel phenanthrene phenol derivative with a spironolactone ring (dendrochrysanene), namely, 2-hydro-7,70,100-trihydroxy-4-40-dimethoxylspiro[(1H)-cyclopenta[a]naphthalene-3,30-(20H)-phenanthro[2,1-b]furan]-1,20-dione, was identified. Results showed anti-inflammatory activity of dendrochrysanene on iNOS mRNA induced by LPS in mouse peritoneal macrophages. Meanwhile, there are several inflammatory cytokines, such as TNF-α, IL-8, and IL-10, which were inhibited. Thus, the beneficial effects of dendrochrysanene compounds as anti-inflammatory agents were identified .
3.3. Sjögren’s Syndrome (SS)
Sjögren’s syndrome (SS) is a chronic autoimmune disease with disorder of the exocrine glands. The symptoms are dry eyes, dry mouth, dry throat and thirst with blurred vision, and so forth. The abnormal distribution of salivary glands in SS leads to an inflammatory effect and pathological processes triggering lymphocyte infiltration and apoptosis. Lymphocyte infiltration and apoptotic pathways, shown by regulation of Bax, Bcl-2, and caspase-3, have been reported in submandibular glands (SG). Furthermore, in pathological processes were also found that the subsequent signal of cell expression to mRNA of proinflammatory cytokines, such 30 as tumor necrosis (TNF-a), interleukin (IL-1β), and IL-6. As well as, a high level of expression of aquaporin-5 (AQP-5) is identified. AQP-5 is one of a water channel protein, and plays an important role in 31 the salivary secretions [73, 74].
Treatment with D. officinale polysaccharides (DP) could suppress the progression of lymphocyte infiltration and apoptosis in SS and rectify the chaos of proinflammatory cytokines including TNF-α, IL-1 beta, and IL-6 in SG [71, 75] (Figure 1). mRNA expression of TNF-α was inhibited. The process of regulation resulted in a series of marked responses, such as translocation of NF-κB, prolonged MAPK, cytochrome C release, and caspase-3 activation, which have been identified [55, 76]. In addition to the findings on DP treatment, there are reports on the findings on the extracts of D. candidum and D. nobile.
A clinical study found that, after 1 week of oral administration of the extract of D. candidum, salivary secretion was increased by approximately 65%. The extract promoted the expression of aquaporin-5 useful for treatment of Sjögren’s syndrome (SS).
Chrysotoxine isolated from D. nobile can increase the expression of AQP-5 in dry eyes, one of the symptoms of SS, and restore the distribution of AQP-5 in lacrimal glands and corneal epithelia, by inhibiting the release of cytokines, such as IL-1, IL-6, and TNF-α. In the meantime, it can activate the mitogen-activated protein kinase (MAPK) signaling pathways. Furthermore, it elicits an increase in the production of matrix metalloproteinase-9 (MMP-9). Ultimately, it leads to an increase of saliva and tear secretion. The medical efficacy of the extracts of D. officinale, D. nobile, and D. candidum species has been demonstrated  (Figure 1).
3.4. Neuroprotective Effect (Parkinsonian Syndrome)
Five bioactive derivatives isolated from Dendrobium species, namely, chrysotoxine (CTX), moscatilin, crepidatin, nobilin B, and chrysotobibenzyl, are potential neuroprotective compounds with antioxidant activity which can be used in the treatment of Parkinson’s disease (PD). The IC50 values of DPPH free radical scavenging activities of chrysotoxine (CTX), moscatilin, crepidatin, and nobilin B were , , , and , respectively. The above data show that crepidatin is better than other compounds in DPPH free radical scavenging capacity. CTX could selectively antagonize MPP+ in dopaminergic pathways in the brain; also 6-hydroxydopamine (6-OHDA) has been inhibited by mitochondrial protection and NF-κB modulation in SH-SY5Y cells. Thus, it could explain how it may be beneficial in preventing PD [44, 77].
In addition, results of CTX compound in Dendrobium nobile Lindl. used in treatment of PD have also been clearly reported. We evaluated the pharmacokinetics of oral (100 mg/kg) and intravenous (25 mg/kg) administration of CTX preparation using high performance liquid chromatography-tandem mass spectrometric (HPLC-MS/MS) method in animal tests . Results indicate efficacy and safety in treating PD conditions. The antioxidant mechanisms towards 6-OHDA and SH-SY5Y and regulation of antiapoptosis in cell signaling pathways were described .
3.5. Immunomodulatory Activity
Lymphocytes can be classified as T lymphocytes, B lymphocytes, and macrophages, respectively. They are important to immune cells and play a key role for reactions and responses in the immune system. Generally, there are various types of lymphocytes which are activated by very complex signal transduction pathways. Among all, the most common type is the action of lipopolysaccharides (LPS) in macrophages, which are able to produce many different kinds of proinflammatory cytokines, especially TNF-α, which is one of the main proinflammatory cytokines and plays a critical role in mediating signal transduction and stimulating the immune defense system . The immunopotentiating action from Dendrobium species produced by concanavalin A- (Con A-) stimulated proliferation of splenocytes in mouse. Finding the part of, which the D. officinalis produced a more potent immunopotentiating action, although it did not provided related to information of biological activity .
Sesquiterpenes from D. nobile showed a comitogenic effect on Con A- and LPS-stimulated mouse splenocytes. Other chemical components, including polysaccharides and sesquiterpene glycosides were also confirmed. Related sesquiterpene glycosides with alloaromadendrane, emmotin, and picrotoxane type aglycones, namely dendroside A, dendronobilosides A. In vitro biological tests suggest the types of polysaccharides and sesquiterpene glycosides (given as dendrosides D–G) significantly promoted cell proliferation and more stimulation of mouse T and/or B lymphocytes [45, 80]. On the other hand, compounds from D. moniliforme, namely, dendroside A, dendroside C, and vanilloloside, were found to stimulate the proliferation of B cells and inhibit the proliferation of T cells in vitro  (Table 6).
|Notes: activation: AD; inhibition: IY.|
Up the table, showed T cell and B cell activated by chemical compounds from D. nobile, and inhibit T cell and activated on B cell by chemical compounds from D. moniliforme.
In addition, the leaf, stem (cell walls), and mucilage isolated of D. huoshanense using chemical and enzymatic analyzed by chromatographic and spectroscopic methods, results demonstrated the bioactivity from polysaccharides and it’s structure, HPS-1B23. The potential effects for main composed of more monosaccharides, showing Xyl, Ara, Man, Glc, Gal, and GalA, by HPS-1B23, signify an increasing immunostimulating activity through upregulating the levels of several cytokines, including TNF-α, IL-10, IL-6, and IL-1 . In addition, the stem cell mucilage polysaccharides of D. huoshanense composed of β-(1-4)-D-Glcp and β-(1-4)-D-Manp linkages with partial acetylated mannosides were identified, which upregulated the growth factors GM-CSF and G-CSF. DHP-4A stimulated RAW 264.7 macrophages to secrete NO, TNF-α, IL-6, and IL-10 by activating p38, ERK, JNK, and NF-κB. The results provide clear scientific evidence on regulation of hematopoietic growth factors and cytokines factors in the immune system by different polysaccharides from D. huoshanense [81, 82]. Interestingly, the total polysaccharides of D. huoshanense induced the expression of interleukin-1 receptor antagonist (IL-1ra) in human monocytes. Which the IL-1ra was regulated by 37 a series of signaling pathways, like ERK/ELK, p38 MAPK, PI3K, and NF-κB .
In addition, the water-soluble polysaccharides (DTP) derived from D. tosaense were isolated by using HPAEC-PAD, HP-SEC, GC–MS, and NMR spectroscopy. They significantly increased the number of natural killer (NK) cells, NK cytotoxicity, macrophage phagocytosis, and cytokine induction in splenocytes, when administered orally to BALB/c mice for 3 weeks .
3.6. Treatment of Diabetes
The compounds isolated from Dendrobium huoshanense (DHP) have been evaluated for treatment of diabetes in recent years. The hypoglycemic and antioxidative activities of three polysaccharides, namely, D. officinale (DOP), D. nobile (DNP), and D. chrysotoxum (DCP), have been compared in diabetic mice. Result showed that the hypoglycemic effect of DHP was better than those of DNP and DOP. In addition, the antioxidant effect of DHP was better than those of DOP and DNP by regulating the superoxide dismutase, catalase, malonaldehyde, and l-glutathione levels in the liver and kidney. Thus, the hypoglycemic and antioxidant activities of DHP need to be studied more extensively in the future .
3.7. Antitumor Activity
3.7.1. The Anticancer Effect of D. chrysotoxum and D. nobile
Fluorenone derivatives, namely, dendroflorin and denchrysan A, isolated from stems of D. chrysotoxum species, show significant inhibitory effects on the growth of human hepatoma BEL-7402 cells. The IC50 values of 1,4,5-trihydroxy-7-methoxy-9H-fluoren-9-one, denchrysan A 1, and dendroflorin were 1.49 μg/mL, 1.38 μg/mL, and 0.97 μg/mL, respectively.
On the other hand, erianin, a phenanthrene from D. chrysanthum, is recognized as an antitumor agent. Reports showed that it has potent inhibitory activity in hepatoma Bel7402, melanoma A375, and HL-60 cells, as evidenced by inhibition of angiogenesis and induction of endothelial cytoskeletal disorganization in vivo and in vitro, but did not show antitumor activity [56, 61]. Thus, further investigation is needed to identify if the antitumor mechanisms of erianin and denbinobin are similar.
The antitumor effects of polysaccharides isolated from stems of D. nobile, namely, DNP-W, DNP-OH, and DNP-H, were studied. DNP-W was further fractionated to give six subfractions including DNP-W1, DNP-W2, DNP-W3, DNP-W4, DNP-W5, and DNP-W6 by using anion exchange chromatography. The results show that DNP-W, DNP-OH and DNP-H, DNP-W1, DNP-W2, and DNP-W3, especially DNP-W1 and DNP-W3, have a strong antitumor action in inhibiting sarcoma 180 in vivo and HL-60 cells in vitro . In addition, denbinobin is a major phenanthrene isolated from stems of D. nobile. The inhibitory mechanisms of denbinobin in SNU-484 cells have been observed. It significantly decreased the expressions of matrix metalloproteinase (MMP-2) and (MMP-9) and induced apoptosis through downregulation of Bcl-2 and upregulation of Bax in cancer cells. These findings may be used to provide reference for further studies on the pharmacological mechanisms from denbinobin and polysaccharides in D. nobile [50, 51, 84].
3.7.2. Antilymphoma Activity of Dendrobium formosum
Lymphoma is a cancer of the immune system. The ethanolic extract of Dendrobium formosum showed antilymphoma activity in vitro as evaluated by the MTT assay. It also significantly prolonged survival time in Dalton’s lymphoma bearing mice .
3.7.3. Anti-Lung-Cancer Activity of Dendrobium draconis
The bibenzyl compound gigantol has been isolated from Dendrobium draconis. It inhibits several cancer cell lines and inhibits filopodia formation of the non-small-cell lung cancer cells. The molecular mechanism of gigantol includes (1) downregulating caveolin-1 (Cav-1), (2) activating ATP-dependent tyrosine kinase, and (3) regulating cell division cycle 42 (Cdc42) .
3.8. Antimicrobial Activity and Antifungal Activity
Dendrobium is an important economic plant; however, there have been certain cultivation issues yet to be resolved, particularly fungal infection . Pythium vexans has been reported to cause stem rot, crown rot, root rot, damping-off, and patch canker in Dendrobium plants . The diseases could lead to damage to the seedlings of D. chrysotoxum, D. chrysanthum, D. thyrsiflorum, and D. aurantiacum, characterized by water-soaked, brown or yellowish lesions with a brown margin, resulting in dieback of the plants within a few days . Interestingly, it also resulted in antimicrobial activity from endophytic bacteria isolated from Dendrobium species. Screening of various endophytic fungi from roots and stems of different Dendrobium species, including 53 endophytic fungi from D. devonianum; 23 endophytic fungi from D. thyrsiflorum by way of morphological and/or molecular biological methods, showed that 10 endophytic fungi from D. devonianum and 11 endophytic fungi from D. thyrsiflorum exhibited strong antimicrobial activity. Phoma, Epicoccum, and Fusarium isolated from two abovementioned Dendrobium species demonstrated antibacterial and antifungal activities. The pyrenophorol derivatives of Phoma possessed antagonistic activity against E. coli, Bacillus megaterium, and Microbotryum violaceum, and Epicoccum sp. slightly inhibited S. aureus, E. coli, and B. subtilis. Fusarium demonstrated inhibitory effect on different pathogens. Moreover, epicorazine A and epicorazine B derivatives of Epicoccum nigrum isolated from D. thyrsiflorum possessed antibacterial activity against S. aureus and B. subtilis and also inhibited the growth of Gram-positive and Gram-negative bacteria, with a potency stronger than that of ampicillin sodium [90–93].
3.9. Antimalarial and Antiherpetic Activities
3.9.1. Antimutagenic Activity
Moscatilin obtained from D. nobile is a naturally occurring antimutagenic bibenzyl compound. This compound can exert a suppressive effect on the mutagenic activity of furylfuramide, 4-nitroquinoline-1-oxide (4NQO), N-methyl-N′-nitro-N-nitrosoguanidine, UV irradiation, 3-amino-1,4-dimethyl-5H-pyridoindole (Trp-P-1), benzo[a]pyrene (B[a]P), and aflatoxin B(1) .
3.10. Diabetic Retinopathy (DR)
Diabetes mellitus (DM) is one of the metabolic diseases. It can cause many complications, such as kidney failure, stroke, and foot ulcers. The ethanol extract of Dendrobium chrysotoxum (DC) used in treatment of diabetic retinopathy reduced the expression of a series of growing factors in DC-treated diabetic rats. It decreased the retinal mRNA expression level of vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 2 (VEGFR2), serum growth factor (SVEGF), matrix metalloproteinase (MMP) 2/9, basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF) A/B, insulin-like growth factor 1 (IGF-1), interleukin 1β (IL-1β), interleukin 6 (IL-6), and phosphorylation of p65. Moreover, a decrease in the expression of intercellular adhesion molecule-1 (ICAM-1) has been reported .
3.11. Antiplatelet Aggregating Activity
Studies on the aggregation of platelets induced through thrombin, arachidonic acid (AA), thrombin, collagen, and platelet-activating factor (PAF) were conducted by using 4 different aggregation inducers. Animal tests disclosed that different Dendrobium species including Dendrobium loddigesii and Dendrobium densiflorum possess antiplatelet aggregating activity. The results indicated some compounds isolated from two Dendrobium species more effectively inhibited AA-induced aggregation than they inhibited aggregation induced by PAF and collagen . In animal tests, the antiplatelet aggregation of D. loddigesii species, which those compounds in part from moscatilin, moscatin and diacetate. They inhibit platelet aggregation was induced by AA was completely abolished by fraction 4 (50 μg/mL) in rabbit platelets. Meanwhile, further demonstrated there are strongly inhibited both AA and collagen-induced platelet aggregations about 100 μg/mL. However, in PAF there are no significant effects. In addition, comparison of different compounds from D. densiflorum species, such as moscatilin, homoeriodictyol, scoparone, scopoletin, and gigantol, which the antiplatelet aggregation activity of their were identified in vitro. Especially for scoparone has been reported to possess potent antiplatelet aggregation who more than other compounds. Thus, it possible interactied by compounds-compounds for antiplatelet aggregation [26, 97, 98] (Table 7).
|Notes: —: no tests; SR: similar.|
In this paper, the history, chemistry, and pharmacology of different Dendrobium species are reviewed. Especially for biological pharmacology (Table 7). The pharmacological activities examined include antioxidant, anti-inflammatory, immunomodulatory, antitumor, antimicrobial/antifungal, antimutagenic activities, and antiplatelet aggregation activities. The ABTS, DPPH, and hydroxyl radical scavenging effects of different polysaccharides such as DNP, DNP2-1, DNP1-1, DNP3-1, and DNP4-2 have been investigated. Loddigesiinol, nobilone, dihydrophenanthrenes, and phenanthrenes have been evaluated for nitric oxide (NO) scavenging effect. Five types of polysaccharides from D. huoshanense, D. chrysotoxum, and D. fimbriatum species were compared. D. huoshanense and D. chrysotoxum polysaccharides exhibited stronger DPPH and hydroxyl scavenging activity while D. fimbriatum polysaccharides have stronger ABTS scavenging activity. Dihydrophenanthrenes and loddigesiinol D were isolated from D. loddigesii and D. nobile species. Dihydrophenanthrenes significantly inhibited DPPH production. Loddigesiinol D significantly inhibited NO production.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
This study was supported by Seed Funding Programme for Basic Research from The University of Hong Kong Project no. 201311159022 and Seed Funding Programme for Basic Research from the University of Hong Kong Project no. 201111159043.
- R. L. Dressler, Phylogeny and Classification of the Orchid Family, Cambridge University Press, New York, NY, USA, 1993.
- D. K. Singh, “Morphological diversity of the orchids of Orissa/Sarat Misra,” in Orchids: Science and Commerce, P. Pathak, R. N. Sehgal, N. Shekhar, M. Sharma, and A. Sood, Eds., p. 35, BSMPS, New Delhi, India, 2001.
- S. P. Vaughan, A. M. Grisoni, A. M. H. Kumagai, and A. A. R. Kuehnle, “Characterization of Hawaiian isolates of Cymbidium mosaic virus (CymMV) co-infecting Dendrobium orchid,” Archives of Virology, vol. 153, no. 6, pp. 1185–1189, 2008.
- M. M. Hossain, “Traditional therapeutic uses of some indigenous orchids of Bangladesh,” Medicinal and Aromatic Plant Science and Biotechnology, vol. 42, no. 1, pp. 101–106, 2009.
- H. P. Wood, The Dendrobiums, Timber Press, Portland, Ore, USA, 2006.
- K. M. Cameron, M. W. Chase, W. M. Whitten et al., “A phylogenetic analysis of the Orchidaceae: evidence from rbcL nucleotide sequences,” American Journal of Botany, vol. 86, no. 2, pp. 208–224, 1999.
- R. L. Dressler, The Orchids: Natural History and Classification, Harvard University Press, Cambridge, Mass, USA, 1981.
- M. A. Clements, “Molecular phylogenetic systematics in the Dendrobiinae (Orchidaceae), with emphasis on Dendrobium section Pedilonum,” Telopea, vol. 10, pp. 247–298, 2003.
- J. Xu, J. Guan, X. J. Chen, J. Zhao, and S. P. Li, “Comparison of polysaccharides from different Dendrobium using saccharide mapping,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 5, pp. 977–983, 2011.
- K. R. Kirtiker and B. D. Basu, Indian Medicinal Plants, IV: Bishen Singh Mohendra Pal Singh, Dehradun, India, 2nd edition, 1975.
- C. J. Bulpitt, “The uses and misuses of orchids in medicine,” QJM, vol. 98, no. 9, pp. 625–631, 2005.
- C. L. Withner, The Orchid: A Scientific Survey, Ronald Press Company, New York, NY, USA, 1959.
- S. P. Das and S. K. Bhattacherjee, “Orchids,” in Herbaceous Perennials and Shade Loving Foliage Plants, S. K. Bhattacherjee, Ed., Pointer Publishers, Jaipur, India, 2006.
- J.-M. Kong, N.-K. Goh, L.-S. Chia, and T.-F. Chia, “Recent advances in traditional plant drugs and orchids,” Acta Pharmacologica Sinica, vol. 24, no. 1, pp. 7–21, 2003.
- M. Li, K. Y.-B. Zhang, P. P.-H. But, and P.-C. Shaw, “Forensically informative nucleotide sequencing (FINS) for the authentication of Chinese medicinal materials,” Chinese Medicine, vol. 6, article 42, 2011.
- T. B. Ng, J. Liu, J. H. Wong et al., “Review of research on Dendrobium, a prized folk medicine,” Applied Microbiology and Biotechnology, vol. 93, no. 5, pp. 1795–1803, 2012.
- C. A. Williams, “The leaf flavonoids of the Orchidaceae,” Phytochemistry, vol. 18, no. 5, pp. 803–813, 1979.
- H. J. Zhang, J. J. Zhou, and X. S. Li, “Study advance of gastrodia elata b1,” Amino Acids and Biotic Resources, vol. 25, no. 1, pp. 17–20, 2003.
- P. L. Majumder, S. Guha, and S. Sen, “Bibenzyl derivatives from the orchid Dendrobium amoenum,” Phytochemistry, vol. 52, no. 7, pp. 1365–1369, 1999.
- Y. Li, C.-L. Wang, Y.-J. Wang et al., “Three new bibenzyl derivatives from Dendrobium candidum,” Chemical and Pharmaceutical Bulletin, vol. 57, no. 2, pp. 218–219, 2009.
- Y. Li, C. L. Wang, S. X. Guo, J. S. Yang, and P. G. Xiao, “Two new compounds from Dendrob-ium candidum,” Chemical and Pharmaceutical Bulletin, vol. 56, pp. 1477–1499, 2008.
- Y. Chen, J. Li, L. Wang, and Y. Liu, “Aromatic compounds from Dendrobium aphyllum,” Biochemical Systematics and Ecology, vol. 36, no. 5-6, pp. 458–460, 2008.
- Y. Chen, Y. Liu, J. Jiang, Y. Zhang, and B. Yin, “Dendronone, a new phenanthrenequinone from Dendrobium cariniferum,” Food Chemistry, vol. 111, no. 1, pp. 11–12, 2008.
- Y. Chen, Y. Li, C. Qing, Y. Zhang, L. Wang, and Y. Liu, “1,4,5-Trihydroxy-7-methoxy-9H-fluoren-9-one, a new cytotoxic compound from Dendrobium chrysotoxum,” Food Chemistry, vol. 108, no. 3, pp. 973–976, 2008.
- H. Yang, G.-X. Chou, Z.-T. Wang, Y.-W. Guo, Z.-B. Hua, and L.-S. Xu, “Two new compounds from Dendrobium chrysotoxum,” Helvetica Chimica Acta, vol. 87, no. 2, pp. 394–399, 2004.
- C. Fan, W. Wang, Y. Wang, G. Qin, and W. Zhao, “Chemical constituents from Dendrobium densiflorum,” Phytochemistry, vol. 57, no. 8, pp. 1255–1258, 2001.
- J.-T. Li, B.-L. Yin, Y. Liu, L.-Q. Wang, and Y.-G. Chen, “Mono-aromatic constituents of Dendrobium longicornu,” Chemistry of Natural Compounds, vol. 45, no. 2, pp. 234–236, 2009.
- X. Zhang, H.-W. Liu, H. Gao et al., “Nine new sesquiterpenes from Dendrobium nobile,” Helvetica Chimica Acta, vol. 90, no. 12, pp. 2386–2394, 2007.
- Q.-F. Liu, W.-L. Chen, J. Tang, and W.-M. Zhao, “Novel bis(bibenzyl) and (propylphenyl)bibenzyl derivatives from Dendrobium nobile,” Helvetica Chimica Acta, vol. 90, no. 9, pp. 1745–1750, 2007.
- G.-N. Zhang, L.-Y. Zhong, S. W. A. Bligh et al., “Bi-bicyclic and bi-tricyclic compounds from Dendrobium thyrsiflorum,” Phytochemistry, vol. 66, no. 10, pp. 1113–1120, 2005.
- Y. Liu, J.-H. Jiang, B.-L. Yin, and Y.-G. Chen, “Chemical constituents of Dendrobium cariniferum,” Chemistry of Natural Compounds, vol. 45, no. 2, pp. 237–238, 2009.
- S.-F. Lo, V. Mulabagal, C.-L. Chen, C.-L. Kuo, and H.-S. Tsay, “Bioguided fractionation and isolation of free radical scavenging components from in vitro propagated chinese medicinal plants Dendrobium tosaense Makino and Dendrobium moniliforme SW,” Journal of Agricultural and Food Chemistry, vol. 52, no. 23, pp. 6916–6919, 2004.
- P. L. Majumder and R. C. Sen, “Moscatilin, a bibenzyl derivative from the orchid Dendrobium moscatum,” Phytochemistry, vol. 26, no. 7, pp. 2121–2124, 1987.
- P. L. Majumder and S. Chatterjee, “Crepidatin, a bibenzyl derivative from the orchid Dendrobium crepidatum,” Phytochemistry, vol. 28, no. 7, pp. 1986–1988, 1989.
- P. L. Majumder and S. Pal (Née Ray), “Rotundatin, a new 9,10-didydrophenanthrene derivative from Dendrobium rotundatum,” Phytochemistry, vol. 31, no. 9, pp. 3225–3228, 1992.
- C. Honda and M. Yamaki, “Phenanthrenes from Dendrobium plicatile,” Phytochemistry, vol. 53, no. 8, pp. 987–990, 2000.
- K. Krohn, U. Loock, K. Paavilainen, B. M. Hausen, H. W. Schmalle, and H. Kiesele, “Synthesis and electrochemistry of annoquinone-A, cypripedin methyl ether, denbinobin and related 1,4-phenanthrenequinones,” Arkivoc, vol. 2001, no. 1, pp. 88–130, 2001.
- X. Zhang, J.-K. Xu, J. Wang et al., “Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile,” Journal of Natural Products, vol. 70, no. 1, pp. 24–28, 2007.
- Y. Li, C.-L. Wang, S.-X. Guo, J.-S. Yang, and P.-G. Xiao, “Two new compounds from Dendrobium candidum,” Chemical and Pharmaceutical Bulletin, vol. 56, no. 10, pp. 1477–1479, 2008.
- A. X. Luo, X. J. He, S. D. Zhou, Y. J. Fan, T. He, and Z. Chun, “In vitro antioxidant activities of a water-soluble polysaccharide derived from Dendrobium nobile Lindl. extracts,” International Journal of Biological Macromolecules, vol. 45, no. 4, pp. 359–363, 2009.
- A. Luo and Y. Fan, “In vitro antioxidant of a water-soluble polysaccharide from Dendrobium fimhriatum Hook.var.oculatum Hook,” International Journal of Molecular Sciences, vol. 12, no. 6, pp. 4068–4079, 2011.
- R. M. Chen, T. G. Chen, T. L. Chen et al., “Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages,” Annals of the New York Academy of Sciences, vol. 1042, pp. 262–271, 2005.
- L. Xiao, T. B. Ng, Y.-B. Feng et al., “Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome,” Phytomedicine, vol. 18, no. 2-3, pp. 194–198, 2011.
- J.-X. Song, P.-C. Shaw, C.-W. Sze et al., “Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-kB modulation,” Neurochemistry International, vol. 57, no. 6, pp. 676–689, 2010.
- Q. Ye, G. Qin, and W. Zhao, “Immunomodulatory sesquiterpene glycosides from Dendrobium nobile,” Phytochemistry, vol. 61, no. 8, pp. 885–890, 2002.
- C. Zhao, Q. Liu, F. Halaweish, B. Shao, Y. Ye, and W. Zhao, “Copacamphane, picrotoxane, and alloaromadendrane sesquiterpene glycosides and phenolic glycosides from Dendrobium moniliforme,” Journal of Natural Products, vol. 66, no. 8, pp. 1140–1143, 2003.
- X. Q. Zha, J. P. Luo, S. Z. Luo, and S. T. Jiang, “Structure identification of a new immunostimulating polysaccharide from the stems of Dendrobium huoshanense,” Carbohydrate Polymers, vol. 69, no. 1, pp. 86–93, 2007.
- J.-H. Wang, J.-P. Luo, X.-Q. Zha, and B.-J. Feng, “Comparison of antitumor activities of different polysaccharide fractions from the stems of Dendrobium nobile Lindl,” Carbohydrate Polymers, vol. 79, no. 1, pp. 114–118, 2010.
- Y. Li, C.-L. Wang, Y.-J. Wang et al., “Four new bibenzyl derivatives from Dendrobium candidum,” Chemical and Pharmaceutical Bulletin, vol. 57, no. 9, pp. 997–999, 2009.
- J. I. Song, Y. J. Kang, H. Y. Yong, Y. C. Kim, and A. Moon, “Denbinobin, a phenanthrene from Dendrobium nobile, inhibits invasion and induces apoptosis in SNU-484 human gastric cancer cells,” Oncology Reports, vol. 27, no. 3, pp. 813–818, 2012.
- J. I. Song, Y. J. Kang, H.-Y. Yong, Y. C. Kim, and A. Moon, “Denbinobin, a phenanthrene from Dendrobium nobile, inhibits invasion and induces apoptosis in SNU-484 human gastric cancer cells,” Oncology Reports, vol. 27, no. 3, pp. 813–818, 2012.
- J.-X. Song, S. C.-W. Sze, T.-B. Ng et al., “Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?” Journal of Ethnopharmacology, vol. 139, no. 3, pp. 698–711, 2012.
- A. Luo, Z. Ge, Y. Fan, Z. Chun, and X. Jin He, “In vitro and in vivo antioxidant activity of a water-soluble polysaccharide from Dendrobium denneanum,” Molecules, vol. 16, no. 2, pp. 1579–1592, 2011.
- Y. Fan, X. He, S. Zhou, A. Luo, T. He, and Z. Chun, “Composition analysis and antioxidant activity of polysaccharide from Dendrobium denneanum,” International Journal of Biological Macromolecules, vol. 45, no. 2, pp. 169–173, 2009.
- X. Lin, P.-C. Shaw, S. C.-W. Sze, Y. Tong, and Y. B. Zhang, “Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sjögren's syndrome mice,” International Immunopharmacology, vol. 11, no. 12, pp. 2025–2032, 2011.
- T.-H. Lin, S.-J. Chang, C.-C. Chen, J.-P. Wang, and L.-T. Tsao, “Two phenanthraquinones from Dendrobium moniliforme,” Journal of Natural Products, vol. 64, no. 8, pp. 1084–1086, 2001.
- D. T. W. Lau, M. Poon, H. Leung, and K. Ko, “Immunopotentiating activity of Dendrobium species in mouse splenocytes,” Chinese Medicine, vol. 2, no. 3, pp. 103–108, 2011.
- J. S. Hwang, S. A. Lee, S. S. Hong et al., “Phenanthrenes from Dendrobium nobile and their inhibition of the LPS-induced production of nitric oxide in macrophage RAW 264.7 cells,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 12, pp. 3785–3787, 2010.
- L. C. Yang, T. J. Lu, C. C. Hsieh, and W. C. Lin, “Characterization and immunomodulatory activity of polysaccharides derived from Dendrobium tosaense,” Carbohydrate Polymers, vol. 111, pp. 856–863, 2014.
- L.-H. Pan, X.-F. Li, M.-N. Wang et al., “Comparison of hypoglycemic and antioxidative effects of polysaccharides from four different Dendrobium species,” International Journal of Biological Macromolecules, vol. 64, pp. 420–427, 2014.
- Y. Chen, Y. Li, C. Qing, Y. Zhang, L. Wang, and Y. Liu, “1,4,5-Trihydroxy-7-methoxy-9H-fluoren-9-one, a new cytotoxic compound from Dendrobium chrysotoxum,” Food Chemistry, vol. 108, no. 3, pp. 973–976, 2008.
- S. Phetsirikoon, S. Ketsa, and W. G. van Doorn, “Chilling injury in Dendrobium inflorescences is alleviated by 1-MCP treatment,” Postharvest Biology and Technology, vol. 67, pp. 144–153, 2012.
- B. Li, J. Wei, X. Wei et al., “Effect of sound wave stress on antioxidant enzyme activities and lipid peroxidation of Dendrobium candidum,” Colloids and Surfaces B: Biointerfaces, vol. 63, no. 2, pp. 269–275, 2008.
- X. Tian and Y. Lei, “Nitric oxide treatment alleviates drought stress in wheat seedlings,” Biologia Plantarum, vol. 50, no. 4, pp. 775–778, 2006.
- H. Fan, T. Li, L. Guan et al., “Effects of exogenous nitric oxide on antioxidation and DNA methylation of Dendrobium huoshanense grown under drought stress,” Plant Cell, Tissue and Organ Culture, vol. 109, no. 2, pp. 307–314, 2012.
- S. F. Lo, S. M. Nalawade, V. Mulabagal et al., “In vitro propagation by asymbiotic seed germination and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity studies of tissue culture raised plants of three medicinally important species of Dendrobium,” Biological and Pharmaceutical Bulletin, vol. 27, no. 5, pp. 731–735, 2004.
- S.-F. Lo, V. Mulabagal, C.-L. Chen, C.-L. Kuo, and H.-S. Tsay, “Bioguided fractionation and isolation of free radical scavenging components from in vitro propagated chinese medicinal plants Dendrobium tosaense Makino and Dendrobium moniliforme SW,” Journal of Agricultural and Food Chemistry, vol. 52, no. 23, pp. 6916–6919, 2004.
- J.-H. Wang, X.-Q. Zha, J.-P. Luo, and X.-F. Yang, “An acetylated galactomannoglucan from the stems of Dendrobium nobile Lindl,” Carbohydrate Research, vol. 345, no. 8, pp. 1023–1027, 2010.
- W.-G. Zhang, R. Zhao, J. Ren et al., “Synthesis and anti-proliferative in-vitro activity of two natural dihydrostilbenes and their analogues,” Archiv der Pharmazie, vol. 340, no. 5, pp. 244–250, 2007.
- C. C. Tian, X. Q. Zha, L. H. Pan, and J. P. Luo, “Structural characterization and antioxidant activity of a low-molecular polysaccharide from Dendrobium huoshanense,” Fitoterapia, vol. 91, pp. 247–255, 2013.
- M. Ito, K. Matsuzaki, J. Wang et al., “New phenanthrenes and stilbenes from Dendrobium loddigesii,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 5, pp. 628–633, 2010.
- L. Yang, L. H. Qin, S. W. A. Bligh et al., “A new phenanthrene with a spirolactone from Dendrobium chrysanthum and its anti-inflammatory activities,” Bioorganic and Medicinal Chemistry, vol. 14, no. 10, pp. 3496–3501, 2006.
- R. I. Fox, “Sjögren's syndrome,” The Lancet, vol. 366, no. 9482, pp. 321–331, 2005.
- Y. P. Ding, L. S. Wu, and L. W. Yu, “Optimized harvesting period for Dendrobium candidum,” China journal Chinese Materia Medica, vol. 23, pp. 458–460, 1998.
- N. Roescher, P. P. Tak, and G. G. Illei, “Cytokines in Sjögren's syndrome: potential therapeutic targets,” Annals of the Rheumatic Diseases, vol. 69, no. 6, pp. 945–948, 2010.
- L. Xiang, C. W. Stephen Sze, T. B. Ng et al., “Polysaccharides of Dendrobium officinale inhibit TNF-α-induced apoptosis in A-253 cell line,” Inflammation Research, vol. 62, no. 3, pp. 313–324, 2013.
- J.-X. Song, P.-C. Shaw, N.-S. Wong et al., “Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP+, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells,” Neuroscience Letters, vol. 521, no. 1, pp. 76–81, 2012.
- J. Fan, L. Guan, Z. Kou, F. Feng, Y. B. Zhang, and W. Liu, “Determination of chrysotoxine in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study,” Journal of Chromatography B, vol. 967, pp. 57–62, 2014.
- M. Liu, J. Li, F. Kong, J. Lin, and Y. Gao, “Induction of immunomodulating cytokines by a new polysaccharide-peptide complex from culture mycelia of Lentinus edodes,” Immunopharmacology, vol. 40, no. 3, pp. 187–198, 1998.
- W. Zhao, Q. Ye, X. Tan et al., “Three new sesquiterpene glycosides from Dendrobium nobile with immunomodulatory activity,” Journal of Natural Products, vol. 64, no. 9, pp. 1196–1200, 2001.
- Y. S.-Y. Hsieh, C. Chien, S. K.-S. Liao et al., “Structure and bioactivity of the polysaccharides in medicinal plant Dendrobium huoshanense,” Bioorganic and Medicinal Chemistry, vol. 16, no. 11, pp. 6054–6068, 2008.
- F. Li, S. H. Cui, X. Q. Zha et al., “Structure and bioactivity of a polysaccharide extracted from protocorm-like bodies of Dendrobium huoshanense,” International Journal of Biological Macromolecules, vol. 72, pp. 664–672, 2015.
- J. Lin, Y.-J. Chang, W.-B. Yang, A. L. Yu, and C.-H. Wong, “The multifaceted effects of polysaccharides isolated from Dendrobium huoshanense on immune functions with the induction of interleukin-1 receptor antagonist (IL-1ra) in monocytes,” PLoS ONE, vol. 9, no. 4, Article ID e94040, 2014.
- H. L. You, J. D. Park, N. I. Baek, S. I. Kim, and B. Z. Ahn, “In vitro and in vivo antitumoral phenanthrenes from the aerial parts of Dendrobium nobile,” Planta Medica, vol. 61, no. 2, pp. 178–180, 1995.
- R. Prasad and B. Koch, “Antitumor activity of ethanolic extract of Dendrobium formosum in T-cell lymphoma: an in vitro and in vivo study,” BioMed Research International, vol. 2014, Article ID 753451, 11 pages, 2014.
- S. Charoenrungruang, P. Chanvorachote, B. Sritularak, and V. Pongrakhananon, “Gigantol, a bibenzyl from Dendrobium draconis, inhibits the migratory behavior of non-small cell lung cancer cells,” Journal of Natural Products, vol. 77, no. 6, pp. 1359–1366, 2014.
- P. Benjaphorn, T. Lalita, N. Ratchaya, and P. Cholakan, “Efficacy of crude extract of antifungal compounds produced from Bacillus subtilis on prevention of anthracnose disease in Dendrobium orchid,” EnvironmentAsia, vol. 5, no. 1, pp. 32–38, 2012.
- Y. Tao, F. Zeng, H. Ho et al., “Pythium vexans causing stem rot of Dendrobium in Yunnan Province, China,” Journal of Phytopathology, vol. 159, no. 4, pp. 255–259, 2011.
- M. E. Barrow Lucero Jr., I. Reyes-Vera, and K. M. Havstad, “Do symbiotic microbes have a role in plant evolution, performance and response to stress?” Communicative & Integrative Biology, vol. 1, pp. 1–5, 2008.
- M. A. Baute, G. Deffieux, R. Baute, and A. Neveu, “New antibiotics from the fungus Epicoccum nigrum. I. Fermentation, isolation and antibacterial properties,” The Journal of Antibiotics, vol. 31, no. 11, pp. 1099–1101, 1978.
- Y. Zhang, S. Liu, Y. Che, and X. Liu, “Epicoccins A-D, epipolythiodioxopiperazines from a Cordyceps-colonizing isolate of Epicoccum nigrum,” Journal of Natural Products, vol. 70, no. 9, pp. 1522–1525, 2007.
- W. Zhang, K. Krohn, H. Egold, S. Draeger, and B. Schulz, “Diversity of antimicrobial pyrenophorol derivatives from an endophytic fungus, Phoma sp.,” European Journal of Organic Chemistry, no. 25, pp. 4320–4328, 2008.
- N. Sattayasai, R. Sudmoon, S. Nuchadomrong et al., “Dendrobium findleyanum agglutinin: production, localization, anti-fungal activity and gene characterization,” Plant Cell Reports, vol. 28, no. 8, pp. 1243–1252, 2009.
- M. Miyazawa, H. Shimamura, S.-I. Nakamura, W. Sugiura, H. Kosaka, and H. Kameoka, “Moscatilin from Dendrobium nobile, a naturally occurring bibenzyl compound with potential antimutagenic activity,” Journal of Agricultural and Food Chemistry, vol. 47, no. 5, pp. 2163–2167, 1999.
- C. Y. Gong, Z. Y. Yu, B. Lu et al., “Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism,” Vascular Pharmacology, vol. 62, no. 3, pp. 134–142, 2014.
- C.-C. Chen, Y.-L. Huang, and C.-M. Teng, “Antiplatelet aggregation principles from Ephemerantha lonchophylla,” Planta Medica, vol. 66, no. 4, pp. 372–374, 2000.
- Y. Okada, N. Miyauchi, K. Suzuki et al., “Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation,” Chemical and Pharmaceutical Bulletin, vol. 43, no. 8, pp. 1385–1387, 1995.
- J.-M. Hu, J.-J. Chen, H. Yu, Y.-X. Zhao, and J. Zhou, “Two novel bibenzyls from Dendrobium trigonopus,” Journal of Asian Natural Products Research, vol. 10, no. 7-8, pp. 653–657, 2008.
Copyright © 2015 Yau Lam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.